-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Telix Pharmaceuticals with Buy Rating, Announces Price Target of $23

Benzinga·07/03/2025 10:54:57
Listen to the news
HC Wainwright & Co. analyst Robert Burns initiates coverage on Telix Pharmaceuticals (NASDAQ:TLX) with a Buy rating and announces Price Target of $23.